World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
30253
World Ranking
15944
National Ranking
837

Peter Bader publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter Bader sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 539 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter Bader D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Bader sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter Bader is affiliated with Goethe University Frankfurt in Germany and has produced extensive research primarily in the field of Medicine. Their work spans several subfields, including Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics, and Pediatrics, Perinatology and Child Health.

The scientist's research focuses on several main topics, notably Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, and CAR-T cell therapy research. Additional areas of study include Childhood Cancer Survivors' Quality of Life, Virus-based gene therapy research, Immunodeficiency and Autoimmune Disorders, and Mesenchymal stem cell research.

Peter Bader has contributed to numerous publications, with frequent appearances in the following venues:

  • Blood
  • Bone Marrow Transplantation
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Leukemia

The scientist often collaborates with several coauthors, including:

  • Christina Peters
  • Franco Locatelli
  • Adriana Balduzzi
  • Jean-Hugues Dalle
  • Selim Corbacioglu

Some recent papers authored or coauthored by Peter Bader include:

  • Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA), 2021, Annals of Oncology
  • Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study, 2020, Journal of Clinical Oncology
  • Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial, 2022, Journal of Clinical Oncology
  • Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes, 2021, Nature Medicine
  • Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort, 2021, Journal of Allergy and Clinical Immunology

Best Publications

  • Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    S. L. Maude;Theodore W Laetsch;J. Buechner;S. Rives

  • Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  • Determinants of Antileukemia Effects of Allogeneic NK Cells

    Wing Leung;Rekha Iyengar;Victoria Turner;Peter Lang

  • Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

    M. Mohty;F. Malard;M. Abecassis;E. Aerts

  • Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

    Arend von Stackelberg;Franco Locatelli;Gerhard Zugmaier;Rupert Handgretinger

  • Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini

  • Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

    Peter Bader;Hermann Kreyenberg;Günter H.R. Henze;Cornelia Eckert

  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

    Eliane Gluckman;Barbara Cappelli;Francoise Bernaudin;Myriam Labopin

  • Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

    A. Sureda;P. Bader;S. Cesaro;P. Dreger

  • Megadose transplantation of purified peripheral blood CD34 + progenitor cells from HLA-mismatched parental donors in children

    R Handgretinger;T Klingebiel;P Lang;P Lang;M Schumm;M Schumm

  • Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

    J R Passweg;H Baldomero;P Bader;C Bonini

  • Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

    M. Mohty;F. Malard;M. Abecassis;E. Aerts

  • Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

    Selim Corbacioglu;Simone Cesaro;Maura Faraci;Dominique Valteau-Couanet

  • Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial

    Franco Locatelli;Peter Nöllke;Marco Zecca;Elisabeth Korthof

  • Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    Ibrahim Yakoub-Agha;Christian Chabannon;Peter Bader;Grzegorz W. Basak

  • Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

    Peter Bader;Hermann Kreyenberg;Walter Hoelle;Gregor Dueckers

  • Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    Rafael F. Duarte;Myriam Labopin;Peter Bader;Grzegorz W. Basak

  • Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

    P Bader;J Beck;A Frey;PG Schlegel

  • How and when should we monitor chimerism after allogeneic stem cell transplantation

    P Bader;D Niethammer;A Willasch;H Kreyenberg

  • Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients

    S. Corbacioglu;E. Carreras;M. Ansari;A. Balduzzi

Frequent Co-Authors

Thomas Klingebiel
Thomas Klingebiel Goethe University Frankfurt
Peter Lang
Peter Lang University of Bern
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Halvard Bonig
Halvard Bonig Goethe University Frankfurt
Dietrich Niethammer
Dietrich Niethammer University of Tübingen
Arjan C. Lankester
Arjan C. Lankester Leiden University Medical Center
Ulrike Koehl
Ulrike Koehl Leipzig University
Myriam Labopin
Myriam Labopin Université Paris Cité
Marco Zecca
Marco Zecca University of Pavia
Charlotte M. Niemeyer
Charlotte M. Niemeyer University of Freiburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or flexible pathways, several top healthcare careers can be pursued online. Earning degrees or certifications through distance learning allows greater flexibility for students balancing work, family, or other obligations.

Pharmacy remains a popular choice, and online PharmD programs now allow students to complete advanced training remotely, preparing them for licensure and clinical roles. Alternatively, a HIM bachelor's degree online can lead to careers managing electronic health records and ensuring medical data accuracy.

Those interested in healthcare administration or billing may consider medical coding certification programs, which equip students with skills to process health insurance claims and medical records. Nursing is also a growing field, with affordable options like the cheapest online FNP program available to those seeking advanced practice roles.

Each of these pathways offers a unique route into healthcare, broadening career prospects beyond traditional, in-person medical degrees.

Best Scientists Citing Peter Bader

Trending Scientists

Recently Published Articles